QS Investors’s Array Biopharma Inc ARRY Stock Holding History

QS Investors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-94,600	Closed	-$4.38M	–	1684
2019 Q2	$4.38M	Hold	94,600	–	–	0.05%	308
2019 Q1	$2.31M	Buy	94,600 +89,952	+1,935%	+$1.87M	0.03%	547
2018 Q4	$67K	Hold	4,648	–	–	﹤0.01%	1414
2018 Q3	$71K	Buy	4,648 +48	+1%	+$736	﹤0.01%	1450
2018 Q2	$77K	Hold	4,600	–	–	﹤0.01%	1461
2018 Q1	$75K	Sell	4,600 -5,900	-56%	-$94.5K	﹤0.01%	1423
2017 Q4	$134K	Buy	+10,500	New	+$119K	﹤0.01%	1329

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

QS Investors's ARRY Position: Q3 2019 in Review

QS Investors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 94,600 shares — an estimated $4.38M sold.

QS Investors first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $4.38M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

QS Investors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
QS Investors sold 94,600 Array Biopharma Inc shares in Q3 2019, an estimated $4.38M.
QS Investors first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
QS Investors's Array Biopharma Inc position peaked at $4.38M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on QS Investors's 13F filing for Q3 2019, filed 14 Nov 2019.